|
2023 Conference Publication Promoting The Australian National Bowel Cancer Screening Program In General Practice: Enabling A Culture Of Prevention Within A Clinical SettingMarinucci, Nicole, Koloski, Natasha A., Whaley, Amanda, Bagnall, Rachel, Shah, Ayesha, Holtmann, Gerald and Goodwin, Belinda (2023). Promoting The Australian National Bowel Cancer Screening Program In General Practice: Enabling A Culture Of Prevention Within A Clinical Setting. Digestive Disease Week (DDW) 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)03243-2 |
|
2023 Conference Publication Density of the mucosal bacterial colonization along the gastrointestinal tract in health and diseaseShah, Ayesha, Sternes, Peter R., Kang, Seungha, Pintos, Camila Ayala, Fairlie, Thomas, Tyson, Gene W., Morrison, Mark and Holtmann, Gerald J. (2023). Density of the mucosal bacterial colonization along the gastrointestinal tract in health and disease. Digestive Disease Week (DDW), Chicago, IL, United States, 6-9 May 2023. Philadelphia, PA, United States: Elsevier. doi: 10.1016/S0016-5085(23)03108-6 |
|
2023 Journal Article Unravelling the controversy with small intestinal bacterial overgrowthShah, Ayesha, Ghoshal, Uday C. and Holtmann, Gerald J. (2023). Unravelling the controversy with small intestinal bacterial overgrowth. Current Opinion in Gastroenterology, 39 (3), 211-218. doi: 10.1097/mog.0000000000000928 |
|
2023 Conference Publication Variations Of The Mucosa Associated Microbiome In Patients With Primary Sclerosing Cholangitis, Ulcerative Colitis And Asymptomatic Controls Along The Gastrointestinal TractShah, Ayesha, Kang, Seungha, Fairlie, Thomas, Morrison, Mark and Holtmann, Gerald J. (2023). Variations Of The Mucosa Associated Microbiome In Patients With Primary Sclerosing Cholangitis, Ulcerative Colitis And Asymptomatic Controls Along The Gastrointestinal Tract. Digestive Disease Week (DDW) 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)01543-3 |
|
2023 Conference Publication Effects Of Biologic Therapy In Primary Sclerosing Cholangitis With And Without Inflammatory Bowel Disease: A Systematic Review And Meta-analysisCallaghan, Gavin B., Shah, Ayesha, Fairlie, Thomas, Jones, Michael P. and Holtmann, Gerald J. (2023). Effects Of Biologic Therapy In Primary Sclerosing Cholangitis With And Without Inflammatory Bowel Disease: A Systematic Review And Meta-analysis. Digestive Disease Week (DDW) 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)01675-x |
|
2023 Journal Article Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsiaShanahan, Erin R., Kang, Seungha, Staudacher, Heidi, Shah, Ayesha, Do, Anh, Burns, Grace, Chachay, Veronique S., Koloski, Natasha A., Keely, Simon, Walker, Marjorie M., Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald J. (2023). Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia. Gut, 72 (5) 326158, 929-938. doi: 10.1136/gutjnl-2021-326158 |
|
2023 Journal Article Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 studyTye-Din, Jason A, Daveson, A James M, Goel, Gautam, Goldstein, Kaela E, Hand, Holly L, Neff, Kristin M, Popp, Alina, Taavela, Juha, Maki, Markku, Isola, Jorma, Williams, Leslie J, Truitt, Kenneth E, Anderson, Robert P, Adams, Atoya, Andrews, Jane M, Behrend, Clint E, Brown, Gregor J E, Chen Yi Mei, Swee Lin, Coates, Allan G, DiMarino, Anthony J, Ee, Hooi, Elliott, David E, Epstein, Roger M, Feyen, Bryan John, Fogel, Ronald P, Friedenberg, Keith Alan, Gearry, Richard B, Gerdis, Michael S, Goldstein, Michael J ... Wilson, Scott A (2023). Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. The Lancet Gastroenterology and Hepatology, 8 (5), 446-457. doi: 10.1016/s2468-1253(22)00428-9 |
|
2023 Conference Publication Post colonoscopy upper gastrointestinal cancers among participants in a faecal immunochemical test -based colorectal cancer screening program: results of a data linkage studyPakneshan, Sahar, Moy, Naomi, Koloski, Natasha A., Shah, Ayesha and Holtmann, Gerald (2023). Post colonoscopy upper gastrointestinal cancers among participants in a faecal immunochemical test -based colorectal cancer screening program: results of a data linkage study. Digestive Disease Week 2023, Chicago, IL, United States, 6-9 May 2023. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(23)03240-7 |
|
2023 Conference Publication Small Intestinal Bacterial Overgrowth As Assessed By An Ingestible Gas Sensing Device: A Prospective Comparison To Both Aspirate And Breath TestingShah, Ayesha, Sahu, Shikha, Pedersen, Holly, Chrimes, Adam F., John, James D., Singh, Madhuri, Ghoshal, Ujjala, Ghoshal, Uday C., Berean, Kyle J. and Holtmann, Gerald J. (2023). Small Intestinal Bacterial Overgrowth As Assessed By An Ingestible Gas Sensing Device: A Prospective Comparison To Both Aspirate And Breath Testing. Digestive Disease Week (DDW) 2023, Chicago, IL United States, 6-9 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(23)01088-0 |
|
2023 Journal Article Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and meta-analysisShah, Ayesha, Pakeerathan, Veenaa, Jones, Michael P., Kashyap, Purna C., Virgo, Kate, Fairlie, Thomas, Morrison, Mark, Ghoshal, Uday C. and Holtmann, Gerald J. (2023). Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and meta-analysis. Journal of Neurogastroenterology and Motility, 29 (2), 132-144. doi: 10.5056/jnm22168 |
|
2023 Journal Article Evaluation of small intestinal bacterial overgrowthGhoshal, Uday C, Ghoshal, Ujjala, Shah, Ayesha and Holtmann, Gerald (2023). Evaluation of small intestinal bacterial overgrowth. Expert Review of Gastroenterology and Hepatology, 17 (5), 461-467. doi: 10.1080/17474124.2023.2207008 |
|
2023 Journal Article Social determinants and participation in fecal occult blood test based colorectal cancer screening: A qualitative systematic review and meta-synthesisMarinucci, Nicole, Moy, Naomi, Koloski, Natasha, Shah, Ayesha, Austin, Glenn, Russell‐Bennett, Rebekah, McGraw, Jacquie, Dulleck, Uwe and Holtmann, Gerald (2023). Social determinants and participation in fecal occult blood test based colorectal cancer screening: A qualitative systematic review and meta-synthesis. Health Promotion Journal of Australia, 35 (1), 9-36. doi: 10.1002/hpja.732 |
|
2023 Journal Article Asia‐Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal SymptomsGwee, Kok‐Ann, Lee, Yeong Yeh, Suzuki, Hidekazu, Ghoshal, Uday Chand, Holtmann, Gerald, Bai, Tao, Barbara, Giovanni, Chen, Min‐hu, Chua, Andrew Seng Boon, Gibson, Peter R., Hou, Xiaohua, Liu, Jinsong, Nakajima, Atsushi, Pratap, Nitesh, Sachdeva, Sanjeev, Siah, Kewin Tien Ho, Soh, Alex Yu Sen, Sugano, Kentaro, Tack, Jan, Tan, Victoria Ping Yi, Tang, Xudong, Walker, Marjorie, Wu, Deng‐Chyang, Xiao, Ying‐Lian, Zulkifli, Khairil Khuzaini and Toh, Clarissa (2023). Asia‐Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms. Journal of Gastroenterology and Hepatology, 38 (2), 197-209. doi: 10.1111/jgh.16046 |
|
2023 Journal Article Placebo effects in functional dyspepsia: causes and implications for clinical trialsJones, Michael P. and Holtmann, Gerald (2023). Placebo effects in functional dyspepsia: causes and implications for clinical trials. Neurogastroenterology and Motility, 35 (2) e14527, 1-6. doi: 10.1111/nmo.14527 |
|
2023 Journal Article Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwideRyder, Robert E.J., Laubner, Katharina, Benes, Marek, Haluzik, Martin, Munro, Lynne, Frydenberg, Harry, Teare, Julian P., Ruban, Aruchana, Fishman, Sigal, Santo, Erwin, Stengel, Rainer, De Jonge, Charlotte, Greve, Jan W., Cohen, Ricardo V., Aboud, Cristina M., Holtmann, Gerald J., Rich, Graeme, McMaster, Jess J., Battelino, Tadej, Kotnik, Primoz, Byrne, James P., Mason, John C., Bessell, Justin, Bascomb, Jeanine, Kow, Lillian, Collins, Janes, Chisholm, Jacob, Pferschy, Peter N., Sourij, Harald ... Seufert, Jochen (2023). Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide. Diabetes Care, 46 (4), e89-e91. doi: 10.2337/dc22-1952 |
|
2023 Journal Article Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsiaBurns, Grace L., Bruce, Jessica K., Minahan, Kyra, Mathe, Andrea, Fairlie, Thomas, Cameron, Raquel, Naudin, Crystal, Nair, Prema M., Potter, Michael D. E., Irani, Mudar Zand, Bollipo, Steven, Foster, Robert, Gan, Lay T., Shah, Ayesha, Koloski, Natasha A., Foster, Paul S., Horvat, Jay C., Veysey, Martin, Holtmann, Gerald, Powell, Nick, Walker, Marjorie M., Talley, Nicholas J. and Keely, Simon (2023). Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia. Frontiers in Immunology, 13 1051632, 1-14. doi: 10.3389/fimmu.2022.1051632 |
|
2022 Journal Article Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trialXiao, Mengli, Zhong, Linda L. D., Lam, Wai Ching, Zhao, Yingpan, Gwee, Kok-Ann, Holtmann, Gerald, Tack, Jan, Suzuki, Hidekazu, Chen, Min-Hu, Xiao, Yinglian, Hou, Xiaohua, Liu, Jinsong, Li, Yang, Tang, Xu-Dong and Lu, Fang (2022). Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial. Trials, 23 (1) 454, 1-10. doi: 10.1186/s13063-022-06396-5 |
|
2022 Journal Article Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activitySternes, P. R., Brett, L., Phipps, J., Ciccia, F., Kenna, T., de Guzman, E., Zimmermann, K., Morrison, M., Holtmann, G., Klingberg, E., Mauro, D., McIvor, C., Forsblad-d’Elia, H. and Brown, M. A. (2022). Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity. Arthritis Research and Therapy, 24 (1) 163, 1-10. doi: 10.1186/s13075-022-02853-3 |
|
2022 Journal Article Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trialFrankel, Adam, Thomson, Iain, Shah, Ayesha, Chen, Chen, Zahir, Syeda Farah, Barbour, Andrew, Holtmann, Gerald and Mark Smithers, B (2022). Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial. BJS Open, 6 (6) zrac132. doi: 10.1093/bjsopen/zrac132 |
|
2022 Journal Article Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economicsMoy, Naomi, Dulleck, Uwe, Shah, Ayesha, Messmann, Helmut, Thrift, Aaron P., Talley, Nicholas J. and Holtmann, Gerald J. (2022). Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics. Gastrointestinal Endoscopy, 96 (5), 735-742.e3. doi: 10.1016/j.gie.2022.05.023 |
